Emerging Clinical Paradigms: Exploring the Relationship between Idiopathic Short Stature and Growth Hormone

Welcome, Guest

Endocrine Today Home

Upcoming Live Events

Thank you for your interest in this activity.


	Emerging Clinical Paradigms: Exploring the Relationship between Idiopathic Short Stature and Growth Hormone
	Author(s)/Faculty: Paul Saenger MD, MACE;Robert Rapaport MD;Kerstin Albertsson-Wikland MD, PhD;Pinchas more Cohen MD;David E Sandberg PhD
	Source: Endocrine Today	Type: Multimedia	Number of Articles: 1
	Release Date: March 2010	Expiration Date: March 18, 2011	Cost: $0.00 / $0.00
	Credit Type: CME	Number of Credit(s): 1.50	Provider:
	OVERVIEW The objective of the activities is address outstanding questions related to the impact of growth hormone therapy on final height and quality of life in patients with idiopathic short stature based on new data from randomized clinical trials, and for learners to utilize this data to apply changes into their clinical practice and improve patient outcomes.

Emerging Clinical Paradigms: Exploring the Relationship between Idiopathic Short Stature and Growth Hormone

There is no fee to participate in this activity thanks to educational grant support provided by Pfizer, Inc.

Requires Login